These findings of genetic evidence that LRRK2 is involved in PD and that the kinase hyperactivation may be a primary culprit were strong drivers of research programmes in academia and industry to understand LRRK2 dysfunction and develop inhibitors of LRRK2 kinase activity. Here, LRRK2 is linked to Parkinson disease.